BIO's Cartier Esham testifies about accelerated approval and other FDA reforms during a House Energy and Commerce Health Subcommittee hearing. • Source: screenshot
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".